Scientists discover way to target rare breast cancer mutation
11/28/2014

UK scientists have identified a drug to target a rare breast cancer mutation that helps drive the disease in around 900 of the 50,000 new cases of breast cancer diagnosed in the UK each year.

Innovative technique for monitoring the physical activity of people with haemophilia
11/28/2014

The research group Intelligent Data Analysis Laboratory from the School of Engineering Universitat de València (UV) and a team of scientists at the Faculty of Physiotherapy led by Professor Felipe...

NICE issues final positive recommendation for national commissioning of Soliris for patients with atypical hemolytic uremic syndrome (aHUS)
11/28/2014

Alexion Pharmaceuticals, Inc. has announced that the National Institute for Health and Care Excellence (NICE) Highly Specialised Technologies Evaluation Committee (EC) has recommended that...

Long-term testosterone therapy does not increase the risk of prostate cancer
11/28/2014

Testosterone (T) therapy is routinely used in men with hypogonadism, a condition in which diminished function of the gonads occurs.

Survival differences seen for advanced-stage laryngeal cancer
11/28/2014

The five-year survival rate for advanced-stage laryngeal cancer was higher than national levels in a small study at a single academic center performing a high rate of surgical therapy, including a...

Gene mutation linked to breast cancer therapy resistance
11/28/2014

A group of Vanderbilt-led investigators has identified a new gene mutation that may explain why some breast cancer patients do not respond to anti-hormone therapy.

AG-120 in IDH1 mutated acute myeloid leukemia shows "dramatic" early phase 1 results
11/28/2014

Results presented by University of Colorado Cancer Center investigator Daniel Pollyea, MD, MS, at the 26th European Organisation for Research and Treatment of Cancer Symposium in Barcelona show...

Selenium compounds boost immune system to fight against cancer
11/28/2014

Cancer types such as melanoma, prostate cancer and certain types of leukaemia weaken the body by over-activating the natural immune system.

New transport system for DNA vaccines could help treat HIV, malaria, HPV and other major illnesses
11/28/2014

A new hybrid vehicle is under development.Its performance isn't measured by the distance it travels, but rather the delivery of its cargo: vaccines that contain genetically engineered DNA to...

Provider-focused intervention improves HPV vaccination rates
11/28/2014

Changing the way doctors practice medicine is difficult, however a new study has shown that combining traditional education with quality improvement and incentives improves Human Papilloma virus...